Jean-louis L. Chiasson

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Increased urinary excretion of hedgehog interacting protein (uHhip) in early diabetic kidney disease.

Increased urinary excretion of hedgehog interacting protein (uHhip) in early diabetic kidney disease.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: July 19, 2019

Use of 4β-Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes.

Use of 4β-Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes.

Journal: Clinical pharmacology and therapeutics

Published: February 06, 2019

Modulation of CYP450 Activities in Patients With Type 2 Diabetes.

Modulation of CYP450 Activities in Patients With Type 2 Diabetes.

Journal: Clinical pharmacology and therapeutics

Published: February 05, 2019

Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case-control pharmacokinetic study.

Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case-control pharmacokinetic study.

Journal: BMJ open

Published: February 14, 2018

Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes.

Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes.

Journal: Scientific reports

Published: February 14, 2018

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.

Journal: The lancet. Diabetes & endocrinology

Published: August 07, 2017

Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants.

Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants.

Journal: American heart journal

Published: June 25, 2017

Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During Exercise.

Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During Exercise.

Journal: Diabetes technology & therapeutics

Published: June 30, 2016

Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial.

Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial.

Journal: Diabetologia

Published: May 25, 2016

Socioeconomic status and glycemic control in adult patients with type 2 diabetes: a mediation analysis.

Socioeconomic status and glycemic control in adult patients with type 2 diabetes: a mediation analysis.

Journal: BMJ open diabetes research & care

Published: December 14, 2015

Longitudinal testing of the Information-Motivation-Behavioral Skills model of self-care among adults with type 2 diabetes.

Longitudinal testing of the Information-Motivation-Behavioral Skills model of self-care among adults with type 2 diabetes.

Journal: Patient education and counseling

Published: September 30, 2015

Response to Comment on Tang et al. Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial. Diabetes Care 2015;38:1339-1346.

Response to Comment on Tang et al. Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial. Diabetes Care 2015;38:1339-1346.

Journal: Diabetes care

Published: August 22, 2015

Showing 1-12 of 30

Last Updated: 09/26/2026